Acurx Pharmaceuticals Announces Agreement for Sale of 825,085 Shares
Acurx Pharmaceuticals has entered into a definitive agreement for the purchase and sale of 825,085 shares of its common stock at a price of $3.03 per share. The total offering is valued at up to $7.1 million.
rt.comAcurx Pharmaceuticals announced on Thursday that it has entered into a definitive agreement for the purchase and sale of an aggregate of 825,085 shares of its common stock. 03 per share or pre-funded warrant. The agreement also allows for pre-funded warrants in lieu of common stock shares.
1 million. Acurx Pharmaceuticals is listed on NASDAQ under the ticker ACXP.
Story Timeline
1 event- 2026-04-16
Acurx Pharmaceuticals announced a definitive agreement for the sale of shares.
1 sourceseekingalpha.com
Potential Impact
- 01
The sale could provide Acurx Pharmaceuticals with significant capital.
- 02
The issuance of pre-funded warrants may attract different types of investors.
Transparency Panel
Related Stories
Washington ExaminerJet Fuel Shortages Threaten Nigerian and European Airlines Amid Rising Prices and Supply Disruptions
Nigerian airlines have warned they may suspend operations from April 20 due to soaring jet fuel prices, while Europe faces potential jet fuel shortages within six weeks amid Strait of Hormuz disruptions. The International Energy Agency has cautioned that flight cancellations coul…
israel365news.comNorthern Israel Council Head Comments on Iran in Lebanon Context
The head of a regional council in northern Israel stated that it is unreasonable to associate the Iranian issue with the Lebanese arena. The comment was made in response to recent discussions involving regional security concerns.
vaticannews.vaSpeaker Comments on Pope Leo XIV and Just War Doctrine
Speaker Mike Johnson stated that Pope Leo XIV does not understand the just war doctrine. The comment was made during a press interaction without further elaboration.